GIM
ZBH icon

Glenmede Investment Management’s Zimmer Biomet ZBH Stock Holding History

Glenmede Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.03M Buy
10,432
+926
+10% +$91.8K 0.01% 699
2025
Q2 		$867K Buy
+9,506
New +$919K ﹤0.01% 758

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Glenmede Investment Management's ZBH Position: Q3 2025 in Review

Glenmede Investment Management increased its Zimmer Biomet (ZBH) stake by 9.7% in Q3 2025, buying an estimated $91.8K and bringing the position to 10,432 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #699.

Glenmede Investment Management first reported a position in ZBH in Q2 2025 and has held it in 2 quarters since. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Glenmede Investment Management held 10,432 shares of Zimmer Biomet worth $1.03M as of Q3 2025.
  • Glenmede Investment Management bought 926 Zimmer Biomet shares in Q3 2025, an estimated $91.8K.
  • Zimmer Biomet made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #699 holding.
  • Glenmede Investment Management first reported a position in Zimmer Biomet in Q2 2025 and has held it in 2 quarters since.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.